Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence

Veterinary and Comparative Oncology

Volumn 7, Issue 3, 2009, Pages 162-172

  Sorenmo, K U ^a,b   Kristiansen, V M ^b   Cofone, M A ^b,c   Shofer, F S ^a   Breen, A M ^b   Langeland, M ^b   Mongil, C M ^d   Grondahl, A M ^b   Teige, J ^b   Goldschmidt, M H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^c Veterinary Specialty Center of Delaware   (United States)

^d Centro de Especialistas Veterinarios de Puerto Rico   (Puerto Rico)

Author keywords

Breast cancer; Comparative oncology; Dog; Malignant transformation; Tumour

Indexed keywords

ADENOCARCINOMA; ADENOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; CARCINOMA; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; MIXED TUMOR; NEOPLASM; PATHOLOGY; RETROSPECTIVE STUDY;

ADENOCARCINOMA; ADENOMA; ANIMALS; CARCINOMA; DOG DISEASES; DOGS; FEMALE; MAMMARY NEOPLASMS, ANIMAL; MIXED TUMOR, MALIGNANT; NEOPLASMS; NEOPLASMS, COMPLEX AND MIXED; NEOPLASMS, GLANDULAR AND EPITHELIAL; RETROSPECTIVE STUDIES;

CANIS FAMILIARIS;

EID: 68549106222     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2009.00184.x     Document Type: Article

References (26)

1. Paolini M and Khanna C. Translation of new cancer treatments from pet dogs to humans. Nature Reviews Cancer 2008; 8: 147-155.
2. Sorenmo KU. Canine mammary gland tumors. In: The Veterinary Clinics of North America; Small Animal Practice; Update in Medical Oncology B Kitchel, ed., Philadelphia, WB Saunders Co, 2003; 573-596.
3. Dorn CR, Taylor DO, Schneider R, Hibbard HH and Klauber MK. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. Journal of the National Cancer Institute 1968; 40: 307-318.
4. Jemal A, Siegel R, Ward E, Hao Y, Murray T and Thun MJ. Cancer statistics 2008. CA A Cancer Journal for Clinicians 2008; 58: 71-96.
5. Glass A, Lacey JV, Carreon D and Hoover R. Breast cancer incidence, 1980-2006: Combined roles of menopausal hormone therapy, screening mammography and estrogen receptor status. Journal of the National Cancer Institute 2007; 99: 1152-1161.
6. Schneider R, Dorn CR and Taylor DON. Factors influencing canine mammary cancer development and postsurgical survival. Journal of the National Cancer Institute 1969; 43: 1249-1261.
7. Bernstein L and Ross RK. Endogenous hormones and breast cancer risk. Epidemiologic Reviews 1993; 15: 48-65.
8. Yager JD and Davidson NE. Estrogen carcinogenesis in breast cancer. New England Journal of Medicine 2006; 354: 270-282.
9. Arpino G, Laucirica R and Elledge RM. Premalignant and in situ breast disease: Biology and clinical implications. Annals of Internal Medicine 2005; 143: 446-457.
10. Hartman L, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankrantz S, Hillman DW, Suman VJ, Johnson Jo, Blake C, Tlsty T, Vachon CM, Melton LJ and Visscher DW. Benign breast disease and the risk of breast cancer. New England Journal of Medicine 2005; 353: 229-237.
11. Alpers CE and Wellings SR. The prevalence of carcinoma in situ in normal and cancer-associated breasts. Human Pathology 1985; 16: 796-807.
12. Bratthauer GL and Tavassoli FA. Assessment of lesions coexisting with various grades of ductal intraepithelial neoplasia of the breast. Virchows Archiv 2004; 444: 340-344.
13. London SJ, Connolly JL, Schnitt SJ and Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. Journal of the American Medical Association 1992; 267: 941-944.
14. Bernstein JL, Thompson WD, Risch N and Holford TR. Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. American Journal of Epidemiology 1992; 136: 925-936.
15. Hartman M, Czene K, Reilly M, Adolfson J, Bergh J, Adami HO, Dickman PW and Hall P. Incidence and prognosis of synchronous and metachronous bilateral breast cancer. Journal of Clinical Oncology 2007; 25: 4210-4216.
16. Allred DC, Mohsin SK and Fuqua SAW. Histologic and biological evolution of human premalignant breast disease. Endocrine-Related Cancer 2001; 8: 47-61.
17. Benjamin SA, Lee AC and Saunders WJ. Classification and behavior of canine mammary epithelial neoplasms based on life-span observations in beagles. Veterinary Pathology 1999; 36: 423-436.
18. Fowler EH, Wilson GP and Koester A. Biologic behavior of canine mammary neoplasms based on a histogenic classification. Veterinary Pathology 1974; 11: 212-229.
19. Misdorp W, Else RW, Hellmen E, Lipscomb TP: Histological classification of mammary tumors of the dog and cat. In: WHO International Histological Classification of Tumors of Domestic Animals,. Second Series, vol VII, Washington DC, Armed Forces Institute of Pathology, American Registry of Pathology, 2001.
20. Stratmann N, Failing K, Richter A and Wehrend A. Mammary tumor recurrence in bitches after regional mastectomy. Veterinary Surgery 2008; 37: 82-86.
21. Antuofermo E, Miller M, Pirino S, Xie J, Badve S and Mohammed SI. Spontaneous mammary intraepithelial lesions in dogs-a model of breast cancer. Cancer Epidemiology, Biomarkers & Prevention 2007; 16: 2247-2257.
22. Cheng J, Qiu S, Raju U, Wolman SR and Worsham MJ. Benign breast disease heterogenecity: Association with histopathology, age and ethnicity. Breast Cancer Research and Treatment 2008; 111: 289-296.
23. Miltenburg DM and Speights AO. Benign breast disease. Obstetrics and Gynecology Clinics of North America 2008; 35: 285-300.
24. Schenider R. Comparison of age, sex, and incidence rates in human and canine breast cancer. Cancer 1970; 26: 419-426.
25. Fearon ER and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
26. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL. Genetic alterations during colorectal tumor development. New England Journal of Medicine 1988; 319: 525-532.